UA135187U - PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL - Google Patents

PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL

Info

Publication number
UA135187U
UA135187U UAU201812406U UAU201812406U UA135187U UA 135187 U UA135187 U UA 135187U UA U201812406 U UAU201812406 U UA U201812406U UA U201812406 U UAU201812406 U UA U201812406U UA 135187 U UA135187 U UA 135187U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
dental gel
directive action
api
gel
Prior art date
Application number
UAU201812406U
Other languages
Ukrainian (uk)
Inventor
Юлія Сергіївна Маслій
Олена Анатоліївна Рубан
Ганна Володимирівна Зайченко
Олена Олегівна Грудницька
Original Assignee
Національний Фармацевтичний Університет
Национальный Фармацевтический Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Фармацевтичний Університет, Национальный Фармацевтический Университет filed Critical Національний Фармацевтичний Університет
Priority to UAU201812406U priority Critical patent/UA135187U/en
Publication of UA135187U publication Critical patent/UA135187U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Фармацевтична композиція багатоспрямованої дії у формі стоматологічного гелю містить активні фармацевтичні інгредієнти (АФІ) природного та синтетичного походження: гелеву основу та воду очищену. Як АФІ використовують настойку "Фітодент", холіну саліцилат 80 % та лідокаїну гідрохлорид.The multi-directional pharmaceutical composition in the form of a dental gel contains active pharmaceutical ingredients (API) of natural and synthetic origin: gel base and purified water. Phytodent tincture, choline salicylate 80% and lidocaine hydrochloride are used as API.

UAU201812406U 2018-12-13 2018-12-13 PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL UA135187U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201812406U UA135187U (en) 2018-12-13 2018-12-13 PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201812406U UA135187U (en) 2018-12-13 2018-12-13 PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL

Publications (1)

Publication Number Publication Date
UA135187U true UA135187U (en) 2019-06-25

Family

ID=74213776

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201812406U UA135187U (en) 2018-12-13 2018-12-13 PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL

Country Status (1)

Country Link
UA (1) UA135187U (en)

Similar Documents

Publication Publication Date Title
EA200601776A1 (en) METADONIC COMPOSITIONS OF LOCAL ACTION AND METHODS OF THEIR APPLICATION
ATE514418T1 (en) RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN
EA202090890A1 (en) COMPOSITION OF PLANT AND SYNTHETIC CANNABINOID OF RAPID-ON-START AND LONGER ACTION
CY1126067T1 (en) FUSIONED PYROLINES THAT ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
CL2020000220A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
EA202091318A1 (en) A PREPARATION CONTAINING GROUP B ADENOVIRUS
MX2022002946A (en) Cdk inhibitors and their use as pharmaceuticals.
CO6771406A2 (en) A combined composition
MX2023001963A (en) Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent.
CR20220355A (en) Compounds active towards nuclear receptors
MX2022007265A (en) Compounds active towards nuclear receptors.
MX2020011534A (en) Stable pharmaceutical formulation.
CL2021000924A1 (en) Use of reboxetine for the treatment of narcolepsy
CY1122829T1 (en) PHARMACEUTICAL COMPOSITION FOR NEUROPATHIC PAIN
AR097678A1 (en) COMPOSITION FOR ORAL CARE THAT INCLUDES A DILUTED GEL OF SODIUM AND CALCIUM ALGINATE
MX2021005910A (en) High concentration protein formulation.
UA135187U (en) PHARMACEUTICAL COMPOSITION OF MULTI-DIRECTIVE ACTION IN THE FORM OF DENTAL GEL
MY186286A (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
BR112019001082A2 (en) levodopa and carbidopa intestinal gel and methods of use
CL2020000221A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
IT201700035757A1 (en) Compositions containing natural active ingredients, their preparation and use in the treatment of constipation
EA202091127A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE
MX2022012260A (en) Compounds active towards nuclear receptors.
MX2022012259A (en) Compounds active towards nuclear receptors.
UA123399U (en) PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE